Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Mucosis

May 19, 2015
Mucosis to Present Data on Intranasal RSV Vaccine SynGEM at MVADS 2015
Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious diseases, announces that its Chief Scientific Officer, Dr. Kees Leenhouts, will present at the Modern Vaccines Adjuvants & Delivery Systems (MVADS) 2015 conference held today at the Leiden University Medical Center in The Netherlands. More

March 25, 2015
Mucosis to Present on Intranasal Respiratory Syncytial Virus Vaccine Candidate SynGEM
Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious diseases, announces today that CEO, Tom Johnston, will present a Company update at BioCapital Europe in Amsterdam on March 26. More

November 10, 2014
Mucosis Presents Data on Intranasal Respiratory Syncytial Virus Vaccine SynGEM at RSV2014 Symposium
Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious diseases, will present research on its lead intranasal vaccine candidate SynGEM, a vaccine candidate being researched to prevent infection with respiratory syncytial virus (RSV). More

March 21, 2011
Mucosis starts clinical study with its lead product, FluGEM
Dutch biotechnology company Mucosis B.V. today announced the start of a Phase 1 clinical study with its lead product FluGEM, a novel improved influenza vaccine for the elderly. More

May 31, 2010
Mucosis receives financial support from the Dutch government for its Flugem program
Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation credit line of approximately 3 million from Agentschap NL, an agency of the Dutch Ministry of Economic Affairs. More

Data


23,650
Tech investments
From our Online Data Service
15,274
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MOther Software
Dec 8€8.5MKnowledge management
Dec 8€0.7MGames
Dec 8€1.8MPayment software
Dec 7€35.0MInternet services
Dec 7€1.7MArtificial Intelligence
Dec 7€10.0MWireless applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises 37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.